Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma

Serial ctDNA testing effectively identified HCC recurrence early, postresection and post-LT. ctDNA was also useful for treatment response monitoring and could help resolve ambiguous imaging results.

Authors

Institutions

Publication Details

Journal
JCO Precision Oncology
Published
2025-07-01
DOI
https://doi.org/10.1200/po-24-00934
Citations
6
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
5.62
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma

Amit Mahipal, Abdullah Esmail, Joseph W. Franses, Adham Jurdi et al.
6 citations
JCO Precision Oncology
Cancer Genomics and Diagnostics
5.62
article

Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma

Amit Mahipal, Abdullah Esmail, Joseph W. Franses, Adham Jurdi, Vasily N. Aushev, R. Mark Ghobrial, Minetta C. Liu, Sudha Kodali, J. Bryce Ortiz, Aiwu Ruth He, Irun Bhan, Juan Carlos Barrera Gutierrez, Arkarachai Fungtammasan, Chris M. Brewer, Alejandro Mejia, Nikolas Naleid, Charuta C. Palsuledesai, Ashish Saharia, Catherine Bridges, Maen Abdelrahim, Mahmoud Ouf, Antony Tin
article en
6 citations

Abstract

Serial ctDNA testing effectively identified HCC recurrence early, postresection and post-LT. ctDNA was also useful for treatment response monitoring and could help resolve ambiguous imaging results.

JCO Precision OncologyVol. 9(9)
Houston Methodist (US), Georgetown University (US), Georgetown University Medical Center (US), University of Chicago (US), Massachusetts General Hospital (US), University Hospitals Seidman Cancer Center (US), Natera (United States) (US), Methodist Dallas Medical Center (US)
Good health and well-being
Openalex Percentile: Top 4%
Cancer Genomics and Diagnostics
5.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.